Cargando…

Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation

We report on a 57 year old female patient who presented in acute respiratory failure with severe generalized weakness. She was previously misdiagnosed for over three decades as polymyositis. She was treated with enzyme replacement therapy (ERT) for over five years, after being diagnosed with late on...

Descripción completa

Detalles Bibliográficos
Autores principales: Maharaj, Mandat, Skidmore, David L., Croul, Sidney E., Brake, David J., Lochmuller, Hanns
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421430/
https://www.ncbi.nlm.nih.gov/pubmed/36046397
http://dx.doi.org/10.1016/j.ymgmr.2022.100896
_version_ 1784777592447959040
author Maharaj, Mandat
Skidmore, David L.
Croul, Sidney E.
Brake, David J.
Lochmuller, Hanns
author_facet Maharaj, Mandat
Skidmore, David L.
Croul, Sidney E.
Brake, David J.
Lochmuller, Hanns
author_sort Maharaj, Mandat
collection PubMed
description We report on a 57 year old female patient who presented in acute respiratory failure with severe generalized weakness. She was previously misdiagnosed for over three decades as polymyositis. She was treated with enzyme replacement therapy (ERT) for over five years, after being diagnosed with late onset Pompe Disease (LOPD). She returned to independent living with the use of non invasive ventilation at nights. ERT should be considered in the management of patients with advanced LOPD and the effects of ERT closely monitored.
format Online
Article
Text
id pubmed-9421430
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94214302022-08-30 Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation Maharaj, Mandat Skidmore, David L. Croul, Sidney E. Brake, David J. Lochmuller, Hanns Mol Genet Metab Rep Case Report We report on a 57 year old female patient who presented in acute respiratory failure with severe generalized weakness. She was previously misdiagnosed for over three decades as polymyositis. She was treated with enzyme replacement therapy (ERT) for over five years, after being diagnosed with late onset Pompe Disease (LOPD). She returned to independent living with the use of non invasive ventilation at nights. ERT should be considered in the management of patients with advanced LOPD and the effects of ERT closely monitored. Elsevier 2022-07-18 /pmc/articles/PMC9421430/ /pubmed/36046397 http://dx.doi.org/10.1016/j.ymgmr.2022.100896 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Maharaj, Mandat
Skidmore, David L.
Croul, Sidney E.
Brake, David J.
Lochmuller, Hanns
Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title_full Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title_fullStr Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title_full_unstemmed Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title_short Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title_sort benefit of 5 years of enzyme replacement therapy in advanced late onset pompe. a case report of misdiagnosis for three decades with acute respiratory failure at presentation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421430/
https://www.ncbi.nlm.nih.gov/pubmed/36046397
http://dx.doi.org/10.1016/j.ymgmr.2022.100896
work_keys_str_mv AT maharajmandat benefitof5yearsofenzymereplacementtherapyinadvancedlateonsetpompeacasereportofmisdiagnosisforthreedecadeswithacuterespiratoryfailureatpresentation
AT skidmoredavidl benefitof5yearsofenzymereplacementtherapyinadvancedlateonsetpompeacasereportofmisdiagnosisforthreedecadeswithacuterespiratoryfailureatpresentation
AT croulsidneye benefitof5yearsofenzymereplacementtherapyinadvancedlateonsetpompeacasereportofmisdiagnosisforthreedecadeswithacuterespiratoryfailureatpresentation
AT brakedavidj benefitof5yearsofenzymereplacementtherapyinadvancedlateonsetpompeacasereportofmisdiagnosisforthreedecadeswithacuterespiratoryfailureatpresentation
AT lochmullerhanns benefitof5yearsofenzymereplacementtherapyinadvancedlateonsetpompeacasereportofmisdiagnosisforthreedecadeswithacuterespiratoryfailureatpresentation